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Retinoids (vitamin A and its derivatives) play essential roles during vertebrate development. Vitamin A deprivation leads
to severe congenital malformations affecting many tissues, including diverse neural crest cell populations and the heart. The
vitamin A signal is transduced by the retinoic acid receptors (RAR, RAR, and RAR). However, these receptors exhibit
considerable functional redundancy, as judged by the mild phenotype of RAR single null mutants relative to the defects
evoked by loss of multiple RARs. To circumvent this redundancy, the endogenous RAR2 allele was replaced with a
ligand-binding RAR mutant (RARE305) by gene targeting in mouse embryonic stem (ES) cells. Chimeric embryos derived
from hemizygous RARE305 ES cells displayed several defects similar to those observed in certain RAR double null mutants,
including hypoplasia or absence of the caudal pharyngeal arches and myocardial deficiencies. The latter defects were not due
to abnormal cardiac specification as affected hearts still expressed chamber-specific markers in an appropriate manner.
Chimeras also displayed cardiac looping anomalies, which were associated with a reduction of Pitx2. This work suggests a
role for RAR signaling in late looping morphogenesis and illustrates the utility of using a dominant-negative gene
substitution approach to circumvent the functional redundancy inherent to the RAR family. © 2002 Elsevier Science (USA)
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chimera.INTRODUCTION
Vitamin A plays critical roles in vertebrate development,
as initially evidenced by vitamin A deprivation (VAD)
studies. VAD in rodents or birds leads to complex congeni-
tal defects involving the eye, genito-urinary system, several
neural crest cell derivatives, the hindbrain, and the heart
and associated vessels (Wilson et al., 1953; Maden et al.,
1996; Heine et al., 1985; Dickman et al., 1997; Zile, 1998).
Most of these defects can be reversed by administration of
exogenous retinoic acid (RA) during specific windows, dem-
onstrating that RA can fulfill embryonic vitamin A require-
ments (Dersch and Zile, 1993; Dickman et al., 1997; Ko-
stetskii et al., 1998, 1999).
Retinoids are required for several aspects of heart devel-
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62opment, including anterior–posterior patterning of the
heart tube, normal development of the myocardium, and
proper cardiac looping (reviewed in Smith and Dickman,
1997; Zile, 1998). Interestingly, excess RA in quails gives
rise to similar cardiac defects, including malpositioning,
situs inversus, and cardiac bifida (Dickman and Smith,
1996). The notable difference is that RA excess truncates
the anterior portion of the heart tube and expands posterior
cardiac markers anteriorly, whereas VAD elicits posterior
truncations (Xavier-Neto et al., 1999; Liberatore et al.,
2000). This is consistent with a requirement for retinoid
signaling in the development of the posterior heart tube.
Indeed, bioactive retinoids are enriched in the atrial and
sinus venosus region of the early heart, coincident with the
expression of the embryonic RA-synthesizing enzyme,
Raldh2 (Moss et al., 1998). In agreement with this, targeted
disruption of Raldh2 in the mouse results in a loss of
posterior cardiac structures, including the atria and sinus
venosa, a thin myocardial wall, and a dilated ventricle
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which fails to undergo cardiac looping (Niederreither et al.,
1999, 2001).
Considerable progress has been made in our understand-
ing of the molecular determinants of left–right asymmetry
in vertebrates. Organ situs is controlled by an evolutionar-
ily conserved cascade of signaling molecules leading to the
activation of the left-specific determinants nodal, lefty2,
and pitx2 in the left lateral plate mesoderm (LPM; reviewed
in Mercola, 1999; Capdevila et al., 2000). The misexpres-
sion of nodal, lefty2, or pitx2 in the right LPM can result in
situs defects, as can the loss of these left-side determinants
(Logan et al., 1998; Lowe et al., 2001; Piedra et al., 1998;
Ryan et al., 1998; Yoshioka et al., 1998). The left–right
pathway can be modified by retinoid signaling, as the
treatment of mouse embryos with excess RA, or an RAR
antagonist, results in aberrant heart looping concomitant
with the misexpression of nodal, lefty2, and pitx2 (Chazaud
et al., 1999; Tsukui et al., 1999; Wasiak and Lohnes, 1999).
Consistent with this, VAD quail embryos display a loss of
nodal and pitx2 expression and heart looping defects (Zile
et al., 2000). Raldh2/ mouse embryos, which are largely
RA-deficient, also display an arrest in looping, although
they exhibit normal nodal and pitx2 expression (Nieder-
reither et al., 2001).
The vitamin A signal is transduced by the retinoic acid
receptors (RAR, , and ; reviewed in Chambon, 1996).
RARs are ligand-dependent transcription factors that bind
to retinoic acid response elements (RAREs) in the promoter
regions of target genes as a heterodimer with a retinoid x
receptor (RXR, , and ) partner. Loss of a single RAR leads
to mild congenital malformations which do not recapitu-
late the fetal VAD phenotype (Lohnes et al., 1993; Lufkin et
al., 1993; Luo et al., 1995). However, double RAR mutants
are severely affected and collectively display all the features
of developmental VAD (Lohnes et al., 1994; Mendelsohn et
al., 1994; Kastner et al., 1995). Combinations of RAR and
RXR null mutants also recapitulate the fetal VAD pheno-
type, consistent with the vitamin A signal being conveyed
by RXR/RAR heterodimers (Kastner et al., 1994, 1997a).
These studies demonstrate that RXR/RAR heterodimers
transduce the retinoid signal during embryogenesis, and
also underscore a high degree of functional overlap among
the RARs.
To circumvent redundancy among the RARs, we have
generated a cell line in which we substituted one RAR
allele with a ligand-binding-deficient receptor. The advan-
tages of this approach are multiple. First, it bypasses the
cumbersome genetics needed to generate triple RAR null
mutants. Second, it allows for specific inhibition of RAR
signaling within a defined spatial–temporal context, in this
case, the RAR expression domain. Finally, chimeric ap-
proaches can allow an inference as to the primary site of
RAR function for a given defect. In this regard, we show
that inhibition of RAR function in foregut endoderm is
associated with aberrant development of the caudal pharyn-
geal arches, consistent with previous work (Dupe´ et al.,
1999; Wendling et al., 2001). We also describe a novel role
for retinoid signaling in late cardiac looping morphogenesis,
which was associated with a reduction in the left-specific
laterality determinant Pitx2. These results demonstrate the
utility of the targeted expression of a dominant-negative
RAR to circumvent functional redundancy in RAR signal-
ing and show a previously unsuspected role for retinoid
signaling in late cardiac looping events.
MATERIALS AND METHODS
Gene Replacement
A dominant-negative mouse RAR2 cDNA was created by using
the oligonucleotide 5-CACAATGCTGGCTTTGAACCCCTTAC-
AGACCTCG-3 for site-directed mutagenesis using the Trans-
former Kit (Clontech), resulting in a glycine-to-glutamic acid
FIG. 1. Gene replacement strategy. (A) The wild type RAR locus
is depicted on the top. Exon 5, encoding the RAR2 5 untranslated
sequences and A domain, and exon 8, common to all RAR
isoforms, are indicated. The targeting vector, shown below the wild
type locus, contains the RARE305 cDNA, a bifunctional thymidine
kinase-neomycin resistance (TK-NEO) fusion gene flanked by loxP
sites (black triangles), and the diphtheria toxin A chain (DTA) 3 to
genomic sequences. Sequences are not drawn to scale. The targeted
locus, shown below the targeting vector, results in the destruction
of the endogenous ATG of RAR2 and replacement by RARE305
sequences. Probes 1 and 2 indicate sequences external and internal
to the targeting vector which were used for Southern blot analysis.
B, BamHI; E, EcoRI; K, KpnI; Rv, EcoRV; Xh, XhoI. (B) Southern
blot analysis of targeted and floxed-out alleles. The initial targeting
event was identified by EcoRI restriction and hybridization to
probe 1 (lane 5 vs 1), and confirmed by digestion with KpnI, BamHI,
and EcoRV. Integration fidelity was confirmed by reprobing the
blot with probe 2 (righthand panel). Following Cre-mediated re-
combination, products hybridizing to probe 1 were unaltered, with
the exception of EcoRV, as predicted. The restriction pattern
recognized by probe 2 was likewise consistent with proper excision
of the selection cassette from the targeted allele (compare lanes
21–24 to lanes 17–20).
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change at amino acid position 305 in the ligand-binding domain.
The mutated RAR2 cDNA (henceforth referred to as RARE305)
was subcloned into a targeting vector containing a bifunctional
thymidine kinase-neomycin (TK-Neo) selection cassette driven by
the phosphoglycerate kinase (PGK) promoter and flanked by loxP
sites. These sequences were cloned into a NotI site engineered
within exon 5 of the RAR locus, resulting in the destruction of the
initiator ATG for the endogenous RAR2 gene. The targeting
construct contained 1.5 kb of homologous genomic sequences
upstream and 5.8 kb downstream of the integration site. An
expression vector encoding diphtheria toxin A chain (DTA; Yagi et
al., 1990) was subcloned 3 of RAR genomic sequences for
negative selection.
R1 ES cells were cultured on mitotically inactivated murine
embryonic fibroblasts under standard conditions (Wurst and Joy-
ner, 1993). Cells were electroporated with 25 g of linearized
targeting vector and selected with G418 for 8–10 days. Genomic
DNA from drug-resistant colonies was restricted with EcoRI, and
targeted clones were identified by using a 350-bp RsaI–BamHI
probe external to the targeting vector (probe 1, Fig. 1). Targeted
clones were expanded and the TK-Neo cassette was excised by
transient transfection with a Cre recombinase expression vector
(Gu et al., 1993). Desired recombinants were identified by Southern
blot analysis following restriction with EcoRV and hybridization
with a 1.6-kb BamHI–EcoRI probe (probe 2, Fig. 1).
Generation of Chimeric Embryos
Two independently targeted ES cell lines were used to generate
chimeric embryos by injection of either C57BL/6 or ROSA26 host
FIG. 2. RARE305 chimeric embryos display pharyngeal arch defects. (A, B) Frontal (A) and left (B) views of an E10.5 wild type embryo.
Frontal (D, G) and left (E, H) views of RARE30543ROSA26 chimeric embryos stained for -gal activity. Scale bar in (A) is 250 m. (C,
F, I) Frontal sections through the pharyngeal regions of wild type (C) and chimeric (F, I) embryos. The section in (C) was stained with eosin
and that in (F) was counter-stained with eosin following -gal staining. The section in (I) was stained for -gal only. a2–a4, second to fourth
aortic arches; B1–B4, first to fourth pharyngeal arches; bc, bulbus cordis; fb, forelimb bud; la, left atrium; lv, left ventricle; o, outflow tract;
P3–P4, third and fourth pharyngeal pouches; rv, right ventricle; 1, first pharyngeal arch; 2, second pharyngeal arch. Scale bar in (C, F, I) is
100 m.
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blastocysts (Hogan et al., 1994; Zambrowicz et al., 1997); embryos
derived from both targeted cell lines in either host exhibited
similar defects. Embryos were dissected at E9.5–E10.5 in PBS and
fixed overnight in freshly prepared 4% paraformaldehyde (PFA) in
PBS at 4°C. Some embryos were subsequently dehydrated through
a methanol series in PBS/0.1% Tween 20 and stored at 20°C for
whole-mount in situ hybridization. For histology, embryos were
dehydrated through an ethanol series, embedded in paraffin, sec-
tioned at 7 m, deparafinized, and processed for hematoxylin and
eosin staining. Some embryos generated from ROSA26 blastocysts
were fixed in 4% PFA at room temperature for 1–2 h, rinsed in PBS,
and stained for -galactosidase activity overnight at 37°C as de-
scribed (Hogan et al., 1994). Embryos were subsequently embedded
and sectioned as above.
Immunohistochemistry
Embryos were fixed in 4% PFA in PBS overnight at 4°C and
processed for staining as described above. Sections were
deparafinized, rehydrated through an ethanol series, treated with
10 mM sodium citrate buffer, and immunohistochemistry was
performed as described previously (Lanctot et al., 1999). Briefly,
samples were blocked in 10% goat serum in PBS/0.2% Tween 20
and reacted with rabbit anti-mouse primary antibodies against
either Pitx2 (P2R10; Hjalt et al., 2000) or ANF (Santa Cruz).
Samples were then rinsed in PBS/0.2% Tween 20, blocked as above,
incubated with biotinylated anti-rabbit secondary antibody (Vector
Labs), and subsequently with horseradish peroxidase-coupled
streptavidin (NEN Life Sciences). Reactivity was revealed with
diaminobenzidine (Sigma) in PBS for 6–8 min. Specimens were
counterstained with methyl green (Sigma) before mounting.
Whole-Mount in Situ Hybridization
Whole-mount in situ hybridization was performed as described
previously (Wilkinson, 1992). Digoxigenin-labeled RNA probes
were synthesized from vectors encoding ventricular myosin light
chain 2 (MLC2v; O’Brien et al., 1993; Bruneau et al., 2001), Tbx5
(Bruneau et al., 1999), or eHand (Srivastava et al., 1995). Expression
was visualized by staining for anti-digoxygenin-coupled alkaline
phosphatase using either BM purple (Roche) or NBT/BCIP.
RESULTS
Targeted Replacement of RAR2 with a Dominant-
Negative Receptor
The RARE305 cDNA was targeted to exon 5 of the RAR
locus, and TK-Neo sequences were subsequently removed
FIG. 3. Pitx2 expression is attenuated in RARE305 chimeras. (A)
Pitx2 immunostaining of a frontal section of an E9.5 wild type
embryo. Note expression in the left splanchnopleure (spl), atrium
(la), and conotruncus (ct) as well as bilateral expression in the
ectoderm of the first pharyngeal arch (red asterix). (B) Pitx2 expres-
sion in frontal sections of an E9.5 RARE43ROSA26 chimera.
Note the reduced Pitx2 expression in the splanchnopleure and left
atrium (spl and la in B, compare with A). Pitx2 in the first arch
ectoderm of the chimera was unaffected (red asterisk in B, compare
to A). Red arrowheads indicate regions of strong host cell contri-
bution. (C) Pitx2 in E10.5 wild type embryos showing expression in
the left wall of the conotruncus (ct), left atrium (la), and left side of
the stomach primordium (st). Black arrowheads indicate the right
limit of expression. (D) Frontal section of a RARE43ROSA26
chimera showing reduced Pitx2 expression in the stomach primor-
dium (st) and left side of the heart (compare D with C). Red
arrowheads identify regions of host contribution. (E, F) Frontal
sections of an E10.5 wild type embryo (E) and a chimera (F)
displaying a reversal in heart looping. Pitx2 expression in the left
myocardial wall of the conotruncus (ct). The atrioventricular canal
(avc; black arrowheads) and left stomach primordium (st) typical of
wild type embryos (W) are absent in the chimera (F), while
expression in the buccopharyngeal region was comparable between
samples (red asterisk). avc, atrioventricular canal; ct, conotruncus;
la, left atrium; ra, right atrium; spl, splanchnopleure; st, stomach
primordium; tr, trabeculae; v, ventricle. All embryos were counter-
stained with methyl green. Scale bar in (A–D) 80 m; (E, F) 160 m.
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by transfection with a Cre recombinase expression vector,
yielding the targeted locus as described in Fig. 1. Expression
of the dominant-negative RAR allele was confirmed by
sequencing of RT-PCR products from ES cells (data not
shown).
Two independently targeted clones were injected into
host blastocysts, and the offspring from several litters were
examined at 3 weeks of age for coat color. Chimeras
exhibited no more than 30% ES cell-derived coat colora-
tion, suggesting that strong contribution of RARE305-
expressing cells was lethal. Consistent with this, RARE305
chimeric embryos exhibited a number of defects, many of
which have been previously described in retinoid receptor
mutants or in Raldh2 null embryos (Kastner et al., 1995;
Chambon, 1996; Dupe´ et al., 1999; Lohnes et al., 1994;
Mendelsohn et al., 1994; Niederreither et al., 1999). Defects
observed at low incidence included pharyngeal arch hyp-
oplasia (7/142 embryos) and neural tube defects (19/142).
Heart defects, consisting primarily of aberrant looping and
associated defects, were the most prevalent malformation,
being observed in approximately 25% of all embryos (34/
142; see also below. Note that these data were derived from
all samples recovered, irrespective of chimerism, and there-
fore likely under-represent the effect of the mutant allele).
Such findings are consistent with a specific inhibitory affect
of RARE305 on the retinoid signaling pathway.
The contribution of RARE305 cells was examined by
using ROSA26 recipient blastocysts. ROSA26 embryos ex-
press -gal ubiquitously throughout development, facilitat-
ing distinction between ES cell and host contributions
(Zambrowicz et al., 1997). RARE305 ES cells were capable
of populating all embryonic tissues examined (e.g., Figs. 2D,
2E, 2G, and 2H; and data not shown), with strong contribu-
tions to certain populations correlating with specific phe-
notypes. Injection of wild type ES cells never gave rise to
such abnormalities in 60 chimeras tested, in agreement
with a specific role for RARE305 in attenuating retinoid
signaling. Below, we describe defects in cardiac and pharyn-
geal arch development observed in these chimeras.
RAR Function Is Required for Development of the
Caudal Pharyngeal Arches
RAR/RAR and RAR/RAR null offspring, as well as
embryos treated with RAR antagonist in culture, exhibit
absent or hypoplastic pharyngeal arches caudal to the
second arch (Dupe´ et al., 1999; Wendling et al., 2000, 2001).
The phenotype of mice null for Raldh2 also supports a
critical role for retinoid signaling in the pharyngeal arches
(Niederreither et al., 1999). As RAR transcripts are abun-
dant in the pharyngeal arches, (Ruberte et al., 1990),
RARE305 chimeras were examined for pharyngeal defects.
Wild type embryos at E10.5 have four externally discern-
able pharyngeal arches, each of which consists of a mesen-
chymal component, derived largely from neural crest cells,
surrounded by ectoderm on the external surface and
endoderm lining the interior border (e.g., Figs. 2B and 2C).
Bilaterally paired aortic arches are found within the interior
of arches 1–4 [see, e.g., the second through fourth (a2–a4)
pharyngeal arches in Fig. 2C]. Strong contribution of
RARE305 cells to the pharyngeal region was frequently
associated with hypoplasia or agenesis of the third and
fourth arches (e.g., Fig. 2F, compare with Fig. 2C). In such
affected embryos, aortic arches were frequently hypoplastic
or absent in the second branchial arch and reduced in the
third arch (e.g., compare a3 in Figs. 2F and 2C).
One chimera was unilaterally affected, with loss of the
fourth pharyngeal arch and hypoplasia of the third pharyn-
geal pouch observed on the right side only (B4 and P3,
respectively; Fig. 2I). In contrast, the pharyngeal arches on
the left side developed essentially normally, with the ex-
ception of the loss of the fourth aortic arch (a4; Fig. 2I,
compare with Fig. 2C). Interestingly, although it developed
normally, the mesenchyme of the fourth arch was derived
almost entirely from RARE305 cells, whereas the underly-
ing endoderm was wild type. This finding is consistent with
prior work suggesting a role for pharyngeal endoderm in
supporting development of the overlying arch. In contrast,
agenesis of the fourth aortic arch was observed in associa-
tion with mutant pharyngeal arch mesenchyme (e.g., B4 in
Fig. 2I).
Cardiac Positioning Defects in RARE305 Chimeras
Aberrant heart looping is observed in VAD avian embryos
(Heine et al., 1985; Dersch and Zile, 1993; Dickman and
Smith, 1996). Although similar defects have not been de-
scribed in any retinoid receptor null mutant, treatment
with RA or an RAR antagonist can affect cardiac looping in
a stage-specific manner in the mouse (reviewed in Cap-
devila et al., 2000). A role for retinoid signaling in looping
morphogenesis is also supported by the finding that Raldh2
null embryos exhibit a block in cardiac looping (Nieder-
reither et al., 1999, 2001).
Consistent with a role for RA in cardiac looping morpho-
genesis, 28% of all chimeras examined in the present study
displayed some form of heart defect, the most common of
which consisted of ventricular malpositioning, evident in
14% of all embryos examined. Such positioning defects
ranged from a slight misalignment of the ventricles (e.g.,
Fig. 2E) to a severe block in cardiac looping (e.g., Fig. 3B). In
two instances, a complete reversal of heart looping was
observed (e.g., Fig. 3F).
Pitx2, a member of the bicoid family of homeobox tran-
scription factors, is a downstream effector of the left–right
pathway (Logan et al., 1998; Piedra et al., 1998; Ryan et al.,
1998; Yoshioka et al., 1998; Campione et al., 2001). It is
expressed in the left LPM and left side of the linear heart
tube during early somite stages and demarcates the left-
ventral side of the heart throughout heart development
(Hjalt et al., 2000; Campione et al., 2001). In the mouse, RA
excess or treatment with an RAR antagonist alters pitx2
expression concomitant with abnormal heart looping
(Chazaud et al., 1999; Tsukui et al., 1999; Wasiak and
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Lohnes, 1999). Moreover, aberrant looping morphogenesis
in VAD quail embryos is associated with a reduction in
nodal and pitx2 expression (Zile et al., 2000). We therefore
investigated Pitx2 as a potential retinoid target involved in
cardiac malpositioning in affected chimeras.
Consistent with previous work, in E9.5 controls, Pitx2
was expressed in the ectoderm of the frontonasal mass and
the mandibular arch, in the left splanchnopleure, and at
lower levels in the caudal aspect of the left wall of the
atrium and conotruncus. (Fig. 3A; Hjalt et al., 2000; Cam-
pione et al., 2001). In the E9.5 chimera in Fig. 3B, rightward
looping of the bulbus cordis was initiated, but the ventricle
failed to complete the looping that normally positions it on
the left side (compare Fig. 3B with Fig. 3A). The heart of this
chimera was largely composed of RARE305 cells, with the
exception of the posterior wall of the presumptive left
atrium, part of the dorsal aspect of the bulbus cordis, and
the myocardium separating the left atrium from the ven-
tricular chamber (red arrowheads in Fig. 3C; and data not
shown). Interestingly, the left posterior atrial wall of the
chimera, which was largely wild type, maintained Pitx2
expression, whereas adjacent splanchnopleure, derived
mainly from RARE305 cells, exhibited reduced Pitx2 (Fig.
3C, compare with Fig. 3A). This attenuation of expression
was specific to LPM derivatives and heart as Pitx2 levels in
the ectoderm of the mandibular arch, derived mostly from
RARE305 cells in this specimen, were unaffected (red aster-
isk in Fig. 3C, compare with Fig. 3A).
At E10.5, Pitx2 expression continues to be asymmetric in
several developing organs, including the heart and primitive
stomach (black arrowheads; Fig. 3C). In more ventral sec-
tions, low levels of Pitx2 were observed in the left ventricle
and the atrioventricular canal (Fig. 3E). Abnormal cardiac
looping was observed in chimeras at E10.5 in which the
ventricles were positioned more dorsally and anteriorly
than in controls (Fig. 3D, compare with Fig. 3C). These
anomalies were associated with reduced Pitx2 levels in the
left stomach primordium, which were composed largely of
RARE305 cells (st in Fig. 3D, compare with Fig. 3C). The
chimera depicted in Fig. 3D also displayed a loss of Pitx2 in
the heart despite considerable wild type cell contribution
(red arrowheads, Fig. 3D). This suggests that RARE305 may
affect cardiac Pitx2 expression in a non-cell-autonomous
manner.
Two chimeras displayed a complete reversal of heart
looping. This defect was associated with a lack of detectable
Pitx2 expression in the heart and stomach, although expres-
sion in the buccopharyngeal ectoderm was unaffected (Fig.
3F, compare with 3E).
Trabecular Deficiency in RARE305 Chimeras
The myocardium develops as a thin layer of cells and
subsequently projects proliferating myoblastic strands of
cells in response to signals from the endocardium; these
cells become the future trabecular system of the heart
(Challice and Viragh, 1973; Fishman and Chien, 1997;
Gassmann et al., 1995; Kaufman, 1992; Lee et al., 1995;
Meyer and Birchmeier, 1995). The thin peripheral myocar-
dial layer begins to thicken at E11.5–E12.5 until it gives rise
to a dense compact layer by E14.5–E16.5 that forms the
ventricular wall. Several retinoid receptor mutants and
VAD fetuses exhibit deficiencies in the compact layer and
aberrant trabeculation (Wilson et al., 1953; Sucov et al.,
1994; Kastner et al., 1994, 1997a; Mendelsohn et al., 1994).
Consistent with this, we observed a deficiency in ventric-
ular trabeculation in a number of chimeras (e.g., Figs. 4D vs
4C).
To characterize the ventricular myocardial deficiency
further, ANF expression was assessed. ANF is initially
detected on the ventral surface of the heart at E8.0. By E9.5,
ANF expression becomes stronger on the outer curvature of
the left ventricle and begins to be expressed in the myocar-
dium of the atria (Christoffels et al., 2000; Zeller et al.,
1987). At E10.5, ANF expression becomes elaborated in the
developing trabeculae of the left ventricle and is detected in
the atria, whereas it is down-regulated in the right ventricle
(compare lv and rv in Fig. 4C; Christoffels et al., 2000;
Zeller et al., 1987).
In E10.5 chimeras displaying reduced trabeculation, ANF
expression was observed in the myoblastic strands in the
left ventricle (Fig. 4F, compare with Fig. 4C). This defi-
ciency varied between affected chimeras, with the speci-
men in Fig. 4F showing a greater reduction than the
chimeras in Fig. 4D or Fig. 4E. This trabecular defect was
apparent as early as E9.5 in a chimera displaying a nearly
complete mutant heart; this specimen also had a severe
block in looping morphogenesis (Fig. 4B, compare with Fig.
4A). These results suggest that RARE305 contribution to
the heart resulted in reduced ventricular trabeculation,
although myocardial specification was not overtly per-
turbed as ANF expression was unaffected (see also below).
Moreover, RARE305-derived tissue still formed trabeculae
(e.g., arrow in Fig. 4E), consistent with previous studies
suggesting a non-cell-autonomous requirement for retinoid
signaling in this process (Chen et al., 1998; Tran and Sucov,
1998). In this regard, it is interesting to note wild type
contribution in proximity to these mutant cells (red aster-
isks in Figs. 4D and 4F).
RXR, as well as RAR/RAR, mutants exhibit myocar-
dial hypoplasia and trabeculation defects which become
overtly apparent only after E11.5 (Sucov et al., 1994; Kast-
ner et al., 1994, 1997a,b). In contrast, ventricular trabecu-
lation in RXR/RXR mutants is severely compromised as
early as E9.5. The RARE305 chimeras therefore appear to
represent an intermediate compromise in retinoid signaling
as regards this particular defect.
Chamber Specification Is Not Affected in RARE305
Chimeras
Given that ANF expression was normal in the chimeras,
irrespective of the severity of the cardiac defects, we exam-
ined the expression of additional cardiac markers including
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ventricular myosin light chain 2 (MLC2v), tbx5, and
eHand.
MLC2v is initially detected in the cardiac crescent at E7.5
(Lyons et al., 1990; O’Brien et al., 1993). In the linear heart
tube, MLC2v expression is strongest in the medial region
fated to give rise to the ventricles (O’Brien et al., 1993;
Christoffels et al., 2000). Strong expression is maintained in
the ventricles and proximal outflow tract at E9.5–E10.5,
with lower levels seen in the atrioventricular canal (Christ-
offels et al., 2000; Figs. 5A and 5B; and data not shown).
MLC2v was not altered in chimeras displaying overt cardiac
looping defects at E9.5 (Figs. 5C–5H, compare with control
in Figs. 5A and 5B) nor at E10.5 (data not shown).
EHand expression is restricted to anterior and posterior
domains of the linear heart tube at E8.5 (Srivastava et al.,
1995). These regions give rise to the outflow tract and left
FIG. 4. Trabecular deficiency in RARE305 chimeras. (A, B) Frontal section of E9.5 wild type (A) or chimeric (B) embryos showing ANF
expression in the wall and trabeculae of the ventricle (v) and the bulbus cordis (bc). Note the highly abnormal cardiac positioning in the
chimera. (C–F) Frontal sections of E10.5 control (C) and chimeric (D–F) embryos, illustrating abundant ANF expression in the developing
trabeculae (tr) and wall of the left ventricle (lv; C). E10.5 chimeras showing a moderate (D) or more severe (E, F) reduction in ventricular
trabeculation retained expression of ANF in the left ventricle in all cases. Scale bar in (A–F) is 80 m. avc, atrioventricular canal; bc, bulbus
cordis; ct, conotruncus; la, left atrium; lv, left ventricle; ra, right atrium; rv, right ventricle; sv, sinus venosus; tr, trabeculae.
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FIG. 5. MLC2v expression is not affected in RARE305 chimeras. (A–H) In situ hybridization for MLC2v in E9.5 wild type (A, B) and
chimeric (C–H) embryos. Frontal (A) and left (B) views of wild type controls showing MLC2v expression throughout the ventricles and
proximal outflow tract (oft). (C, E, G) Frontal and (D, F, H) left views of three E9.5 chimeras displaying various degrees of abnormal cardiac
looping. White bar traces the axis along the presumptive right and left ventricles. Scale bar in (A–H) is 400 m. bc, bulbus cordis; la, left
atrium; lv, left ventricle; oft, outflow tract; ra, right atrium; rv, right ventricle.
FIG. 6. Expression of eHand is not affected in RARE305 chimeras. Frontal (A) and left (B) views of eHand expression in E10.5 wild type
embryos in the left ventricle (lv) and outer curvature of the outflow tract (oft). (C, E, G) Frontal and (D, F, H) left views of three chimeras
displaying abnormal looping. The white bar traces the axis along the presumptive right and left ventricles. Note the strong eHand
expression in the left ventricle (lv) and outflow tract (oft). Scale bar in (A–H) is 400 m. la, left atrium; lv, left ventricle; oft, outflow tract;
rv, right ventricle.
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ventricle, respectively, which continue to exhibit eHand
transcripts at E10.5 (Srivastava et al., 1995; Figs. 6A and 6B).
No differences in eHand expression were observed in E10.5
chimeras with overt heart defects (Figs. 6C–6H).
Tbx5 is expressed as a posterior high gradient in the linear
heart tube (Chapman et al., 1996; Bruneau et al., 1999). At
E9.5, tbx5 transcripts are detected in the presumptive right
and left ventricles and in both atrial chambers, with greater
expression in the left ventricle relative to the right (Chap-
man et al., 1996; Bruneau et al., 1999; Figs. 7A–7C). Thus,
tbx5 demarcates structures arising from the posterior heart
tube (Christoffels et al., 2000). As with other chamber-
specific markers, no difference in tbx5 expression was
detected in affected chimeras (Figs. 7D–7F).
DISCUSSION
Although the RA signal is transduced by the RARs,
results from the targeted mutagenesis of this receptor
family have demonstrated a considerable degree of func-
tional redundancy (Kastner et al., 1995; Chambon, 1996).
The present study attempted to circumvent this problem by
substituting RAR with a dominant-negative receptor in ES
cells. We present evidence that this mutant interferes
specifically with retinoid-dependent events and suggest a
novel role for retinoid signaling in late cardiac looping
morphogenesis involving the laterality effector, Pitx2.
A Novel Model for Retinoid Signaling Deficiency in
the Mouse
A dominant-negative RAR was previously created by
modeling an inherited mutation in the ligand-binding do-
main of thyroid hormone receptor  that leads to general-
ized thyroid hormone resistance (Saitou et al., 1994, 1995;
Yamaguchi et al., 1998). It is believed that this mutation
leads to a loss of ligand binding, resulting in stable associa-
tion of corepressors and a block of transcription at target
gene promoters. An identical mutation in RAR has been
used to model retinoid function in skin and vertebrae
(Saitou et al., 1995; Yamaguchi et al., 1998). We have
created the corresponding mutation in the mouse RAR
cDNA, referred to as RARE305, and targeted it to the RAR
locus in ES cells. Chimeras generated from these cell lines
displayed pharyngeal arch defects and ventricular trabecu-
lation deficiencies similar to those defects observed in
certain retinoid receptor null embryos (Kastner et al., 1994;
Mendelsohn et al., 1994; Wendling et al., 2000, 2001).
The recapitulation of defects previously associated with
inhibition of vitamin A signaling strongly supports a spe-
cific effect of the RARE305 allele on the retinoid pathway.
It was notable, however, that these defects manifested in
chimeras derived from ES cells harboring only one copy of
the mutant allele. As these defects are more severe than
those observed in any RAR single null mouse, this finding
suggests that the mutant receptor is a potent dominant
negative. Based on studies of the cognate thyroid hormone
receptor  mutant, this may be explained through loss of
ligand binding and strong association with corepressors
(Yoh et al., 1997), potentially blocking target gene access to
the residual wild type RARs.
RAR305 Affects Retinoid Signaling
Pan-RAR antagonist treatment, or the combined loss of
certain RARs, leads to hypoplastic or agenic caudal pharyn-
geal arches and associated structures (Dupe´ et al., 1999;
Wendling et al., 2000, 2001). Contribution of RARE305 cells
appeared to reproduce several of these defects, consistent
with the pattern of expression of RAR (Ruberte et al.,
1990). Furthermore, population of mutant cells in the arch
mesenchyme was associated with a reduction or loss of the
cognate aortic arch, an effect seen previously in RAR double
mutants and RAR antagonist-treated embryos (Dupe´ et al.,
1999; Wendling et al., 2000). Interestingly, wild type con-
tribution to the pharyngeal endoderm was associated with
normal caudal pharyngeal arches, despite strong contribu-
tion of RARE305 to the arch mesenchyme. This is in
agreement with prior studies suggesting a requirement for
retinoids in the pharyngeal endoderm necessary for the
proper development of the caudal pharyngeal arches (Wend-
ling et al., 2000). In contrast, development of the third and
fourth aortic arches appeared to depend on wild type pha-
ryngeal arch mesenchyme.
Disruption of certain retinoid receptors leads to myocar-
dial deficiencies, particularly of the compact layer (Mendel-
sohn et al., 1994; Kastner et al., 1994, 1997a, b; Sucov et al.,
1994). This may reflect a non-cell-autonomous requirement
for retinoid signaling, as embryos containing hearts com-
posed largely of RXR/ cells develop normally (Chen et
al., 1998; Tran and Sucov, 1998). Our results also demon-
strate a requirement for RAR signaling in myocardial de-
velopment, as ventricular trabeculation was compromised
in chimeras containing strong RARE305 contribution to the
heart, although the mutant cells could form trabeculae.
This deficiency was intermediate between that noted for
RXR single and RXR/RXR double null mutants and was
also less severe than the defects seen in Raldh2 null
offspring. These observations again suggest a potent, al-
though incomplete, attenuation of retinoid signaling by a
single RARE305 allele.
Chimeric hearts required considerable contribution by
mutant cells to evoke trabecular defects, suggesting that
localized signaling from wild type cells can rescue the
deficiency in retinoid signaling. Paracrine signaling under-
lies the development of the trabeculae (reviewed in Fish-
man and Chien, 1997), and the presence of a limited
number of wild type cells within chimeric hearts seems
sufficient to support trabeculation, albeit in a compromised
manner. The finding that RARE305 cells could form trabec-
ulae offers further evidence for a non-cell-autonomous
function for retinoid signaling in the heart, as previously
suggested (Chen et al., 1998; Tran and Sucov, 1998).
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The expression of MLC2v, eHand, tbx5, and ANF was not
altered in chimeras exhibiting cardiac defects, demonstrat-
ing that chamber specification was not overtly affected.
Cardiac-specific transcription was also largely unperturbed
in Raldh2/ mutants, with the exception of loss of tbx5
transcripts, despite the severe defects in this mutant
(Niederreither et al., 2001). Retinoid signaling thus appears
to be required for development of the myocardium and
posterior heart, but not for the patterning of the ventricles
and outflow tract per se.
Retinoid Signaling Is Required for Normal Cardiac
Looping
Retinoid signaling is required for proper cardiac looping
morphogenesis (Niederreither et al., 1999, 2001; Smith and
Dickman, 1997; Zile, 1998). These studies suggest that
retinoids regulate the effectors of the laterality cascade or
affect the ability of the heart to interpret this information
(Dersch and Zile, 1993; Zile et al., 2000). Consistent with
this, RARE305 chimeric embryos often displayed defects
associated with aberrant cardiac looping. Hearts frequently
initiated proper rightward looping but had misplaced ven-
tricles or outflow tracts, ranging from varying degrees of
incomplete looping to an arrest in morphogenesis; on rare
instances, a reversal of cardiac looping was observed. At
least some of these anomalies may be due to the failure of
the proximal outflow tract to displace completely to the left
despite initiating looping correctly, in agreement with
previous work on VAD quails (Zile et al., 2000).
Certain retinoid receptor null mutants exhibit a thin
myocardial wall due to precocious ventricular cardiomyo-
cyte differentiation, and absence of outflow tract septation
(Mendelsohn et al., 1994; Kastner et al., 1994, 1997a,b;
Sucov et al., 1994). However, these studies failed to illus-
trate a role for the RARs in cardiac looping morphogenesis,
in contrast to the aberrant looping observed in VAD studies
in avians (Dersch and Zile, 1993; Heine et al., 1985;
Kostetskii et al., 1998; Zile et al., 2000). A possible expla-
nation for this discrepancy is that there remains sufficient
retinoid signaling in the retinoid receptor null mutants to
direct cardiac laterality. Such a possibility is consistent
with the defects seen in Raldh2 null mutants, which
exhibit a linear heart tube (Niederreither et al., 2001).
In VAD quail embryos, abnormal cardiac looping occurs
concomitant with reduction of nodal and pitx2 expression
in the left LPM, whereas the asymmetric determinants
actRIIA, shh, fgf8, caronte, and lefty1 are unaffected (Zile et
al., 2000). Pitx2 is considered to be an important determi-
nant of organ situs, presumably interpreting signals from
the laterality cascade (Semina et al., 1996; Logan et al.,
1998; Piedra et al., 1998; Ryan et al., 1998; Kitamura et al.,
1999; Lin et al., 1999; Liu et al., 2001; Lu et al., 1999). In
support of this, loss of pitx2 is associated with situs
abnormalities of the lungs, gut, and posterior heart compo-
nents (Kitamura et al., 1999; Lin et al., 1999; Liu et al.,
2001). Furthermore, the dosage of Pitx2 protein was re-
cently suggested to be critical for organ situs (Liu et al.,
2001).
As with VAD quail embryos, we also observed a reduc-
tion in Pitx2 expression in the derivatives of the left LPM
and in the hearts of chimeras displaying looping defects,
with the greatest decrease occurring in a chimera that had
undergone a complete reversal of heart situs. Loss of Pitx2
in the hearts was not strictly correlated with RARE305
contribution, suggesting a non-cell-autonomous require-
ment for retinoid signaling in the heart (see below).
All known components of the retinoid signaling pathway
are expressed symmetrically throughout early embryogen-
sis, and RA distribution has no known laterality bias at the
stages relevant to heart looping (Fujii et al., 1997; Nieder-
reither et al., 1997; Rossant et al., 1991; Ruberte et al.,
1990, 1991; Maden et al., 1998). Thus, retinoid signaling is
unlikely to be directly involved in the establishment of the
left–right axis but may be involved in maintaining expres-
sion of the left-specific effectors, or to provide competence
to interpret this information, as suggested previously (Zile
et al., 2000). In support of this, The pitx2 asymmetric
enhancer contains Nodal and Nkx2.5 response elements,
and the deletion of the latter motif results in a loss of
promoter activity at later stages (Shiratori et al., 2001). Our
results suggest that retinoid signaling also contributes to
the maintenance of pitx2 expression in a similar manner.
Such a possibility is consistent with a role for RA in
affecting competency to respond to laterality signals, as
previously suggested (Zile et al., 2001).
Heart looping involves a complex series of morphoge-
netic processes leading to a dextral-looped heart with the
correct positioning of the outflow tract and the atria (re-
viewed in Manner, 2000). Briefly, this process involves the
transformation of the linear heart tube to a dextral c-shaped
loop that subsequently undergoes a rightward rotation in
the ventricular region and the displacement of the outflow
tract to the right of the body. The latter two processes
convert the initial c-shaped heart loop to an s-shaped one
(Manner, 2000). Both of these processes seemed to be
affected by altered retinoid signaling as RARE305 chimeras
displayed medially positioned ventricles and an abnormal
shift of the outflow tracts. This suggests that retinoid
signaling can affect later aspects of looping, possibly
through altered pitx2 expression.
On rare instances, we observed a complete reversal of
cardiac looping in association with a severe reduction of
pitx2 expression in left LPM derivatives and the heart. The
low incidence of this defect may reflect low, stochastic
levels of expression of RARE305 within the LPM, which
only occasionally suffice to affect laterality processes at
earlier stages. Alternatively, although such anomalies were
not observed in control chimeras, this defect may reflect an
artifact of experimental manipulation which arises at a low
incidence.
Our results differ from those described for the Raldh2
null mutant, which does not exhibit altered pitx2 expres-
sion despite a block in cardiac looping (Niederreither et al.,
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2001). A possible explanation for this discrepancy may be
that the severe deficiency in retinoid signaling in the
Raldh2 mutant results in a block in heart looping due to
mechanical constraints imposed by the loss of posterior
cardiac tissue. Moreover, pitx2 expression was examined a
full day earlier in Raldh2 mutants than in the present study
(Niederreither et al., 2001). This discrepancy is consistent
with an affect of retinoids on pitx2 at later stages, as
discussed above.
In conclusion, we describe a novel approach to analysis of
RAR function, which circumvents, at least to a degree, the
functional redundancy inherent to this receptor family.
Chimeras exhibited a number of defects typical of other
models of retinoid signaling deficiency, suggesting a spe-
cific inhibition of RAR function. The restricted expression
of the dominant-negative RAR, in combination with chi-
meric analysis, offers a viable means to examine retinoid-
dependent ontogenic processes, and should reveal further
roles for retinoid signaling during mammalian embryogen-
esis.
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